Arax Advisory Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.58M | Buy |
73,240
+61,999
| +552% | +$5.53M | 0.05% | 370 |
|
|
2026
Q1 | $807K | Sell |
11,241
-11,495
| -51% | -$885K | 0.02% | 480 |
|
|
2025
Q4 | $1.8M | Sell |
22,736
-94,303
| -81% | -$7.43M | 0.05% | 260 |
|
|
2025
Q3 | $8.82M | Buy |
117,039
+114,408
| +4,348% | +$7.84M | 0.13% | 120 |
|
|
2025
Q2 | $185K | Buy |
2,631
+1,635
| +164% | +$107K | 0.01% | 678 |
|
|
2025
Q1 | $67.5K | Sell |
996
-1,556
| -61% | -$93.1K | ﹤0.01% | 849 |
|
|
2024
Q4 | $115K | Buy |
2,552
+569
| +29% | +$31.9K | 0.01% | 637 |
|
|
2024
Q3 | $125K | Sell |
1,983
-132
| -6% | -$7.7K | 0.01% | 450 |
|
|
2024
Q2 | $125K | Buy |
2,115
+1,995
| +1,663% | +$125K | 0.01% | 431 |
|
|
2024
Q1 | $9.59K | Sell |
120
-19
| -14% | -$1.45K | ﹤0.01% | 782 |
|
|
2023
Q4 | $11K | Sell |
139
-7
| -5% | -$498 | ﹤0.01% | 752 |
|
|
2023
Q3 | $10.2K | Sell |
146
-49
| -25% | -$3.47K | ﹤0.01% | 716 |
|
|
2023
Q2 | $13.5K | Buy |
195
+40
| +26% | +$2.85K | ﹤0.01% | 657 |
|
|
2023
Q1 | $11.5K | Buy |
155
+31
| +25% | +$2.6K | ﹤0.01% | 666 |
|
|
2022
Q4 | $11.6K | Sell |
124
-160
| -56% | -$15.4K | ﹤0.01% | 630 |
|
|
2022
Q3 | $27K | Buy |
284
+146
| +106% | +$14.5K | ﹤0.01% | 521 |
|
|
2022
Q2 | $13K | Buy |
138
+25
| +22% | +$2.44K | ﹤0.01% | 615 |
|
|
2022
Q1 | $11K | Buy |
113
+63
| +126% | +$6.62K | ﹤0.01% | 640 |
|
|
2021
Q4 | $5K | Buy |
50
+25
| +100% | +$2.31K | ﹤0.01% | 754 |
|
|
2021
Q3 | $2K | Sell |
25
-200
| -89% | -$16.8K | ﹤0.01% | 839 |
|
|
2021
Q2 | $19K | Buy |
+225
| New | +$18.4K | ﹤0.01% | 583 |
|
|
2020
Q4 | $29K | Sell |
425
-77
| -15% | -$5.01K | ﹤0.01% | 467 |
|
|
2020
Q3 | $29K | Sell |
502
-1,501
| -75% | -$93.4K | ﹤0.01% | 438 |
|
|
2020
Q2 | $130K | Hold |
2,003
| – | – | 0.02% | 217 |
|
|
2020
Q1 | $119K | Buy |
2,003
+25
| +1% | +$1.67K | 0.03% | 207 |
|
|
2019
Q4 | $147K | Hold |
1,978
| – | – | 0.04% | 198 |
|
|
2019
Q3 | $125K | Sell |
1,978
-1,021
| -34% | -$60.5K | 0.04% | 212 |
|
|
2019
Q2 | $163K | Buy |
+2,999
| New | +$162K | 0.05% | 166 |
|
|
2018
Q4 | $183K | Buy |
2,796
+755
| +37% | +$56.4K | 0.07% | 132 |
|
|
2018
Q3 | $161K | Buy |
2,041
+553
| +37% | +$39.5K | 0.06% | 137 |
|
|
2018
Q2 | $95K | Buy |
1,488
+114
| +8% | +$7.51K | 0.04% | 161 |
|
|
2018
Q1 | $85K | Sell |
1,374
-886
| -39% | -$63.6K | 0.04% | 150 |
|
|
2017
Q4 | $163K | Sell |
2,260
-352
| -13% | -$25.6K | 0.07% | 113 |
|
|
2017
Q3 | $212K | Sell |
2,612
-180
| -6% | -$14.2K | 0.1% | 85 |
|
|
2017
Q2 | $225K | Buy |
2,792
+536
| +24% | +$42.3K | 0.11% | 82 |
|
|
2017
Q1 | $177K | Buy |
2,256
+734
| +48% | +$58.6K | 0.09% | 76 |
|
|
2016
Q4 | $120K | Buy |
+1,522
| New | +$123K | 0.06% | 102 |
|
Other funds holding CVS
Arax Advisory Partners's CVS Position: Q2 2026 in Review
Arax Advisory Partners increased its CVS Health (CVS) stake by 552% in Q2 2026, buying an estimated $5.53M and bringing the position to 73,240 shares worth $7.58M. The position accounts for 0.05% of the portfolio, ranked #370.
Arax Advisory Partners first reported a position in CVS in Q4 2016 and has held it in 37 quarters since. The position peaked at $8.82M in Q3 2025. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Arax Advisory Partners held 73,240 shares of CVS Health worth $7.58M as of Q2 2026.
- Arax Advisory Partners bought 61,999 CVS Health shares in Q2 2026, an estimated $5.53M.
- CVS Health made up 0.05% of Arax Advisory Partners's portfolio in Q2 2026, its #370 holding.
- Arax Advisory Partners first reported a position in CVS Health in Q4 2016 and has held it in 37 quarters since.
- Arax Advisory Partners's CVS Health position peaked at $8.82M in Q3 2025.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.